October 18, 2024
Baxter to Import 18,000 Tons of IV Fluids by Year-End Amid Ongoing Hurricane Recovery Efforts
Baxter International, IV fluid shortage, Hurricane Helene, North Carolina, importation plans, healthcare crisis
Merck’s Clesrovimab Shows Promising Results in Preventing RSV Disease and Hospitalizations in Infants
Clesrovimab, Respiratory Syncytial Virus (RSV), RSV Disease Prevention, Infant Health, Monoclonal Antibody, Clinical Trials, Merck & Co.
FDA Delays Decision on Amgen’s Lumakras and Vectibix Combination for Metastatic Colorectal Cancer
FDA, Amgen, Lumakras, Vectibix, metastatic colorectal cancer, KRAS G12C mutation, sotorasib, panitumumab
Terray Therapeutics Secures $120M Series B Funding to Advance AI-Driven Small Molecule Drug Development
AI-driven drug discovery, small molecule development, Terray Therapeutics, series B funding, biotechnology, pharmaceutical innovation.
FDA Approves Avadel’s Lumryz for Pediatric Narcolepsy Patients
Avadel Pharmaceuticals, Lumryz, narcolepsy, pediatric patients, FDA approval, sodium oxybate, cataplexy, excessive daytime sleepiness (EDS)
FDA Approves Vyalev: A Breakthrough Continuous Infusion Therapy for Advanced Parkinson’s Disease
Vyalev, Parkinson’s disease, continuous infusion therapy, FDA approval, AbbVie, motor fluctuations, levodopa, carbidopa